Guardant Health's Shield blood test for colorectal cancer screening is now covered by TRICARE, providing active duty service ...

The space agency aims to send four astronauts around the moon early next year—and bring them safely home through intense heat ...

Colonoscopy is the gold standard for detecting colon cancer, but every year about 50 million people in the U.S. who qualify for a colonoscopy don't get it done, according to the American Cancer ...

Guardant Health, Inc., a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening is now covered for active-duty service members and their families ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced new real-world data published in Current Medical Research and Opinion finding that the Shield blood-based ...

FDA reviewers questioned the potential benefits of Guardant Health's blood-based test for colorectal cancer (CRC) screening in documents released ahead of an advisory committee meeting on Thursday.

Colorectal cancer is the second-leading cause of cancer-related death in the U.S., even though it is highly treatable if caught early.2 The American Cancer Society estimates that more than 150,000 ...